Collectively, our in vitro data demonstrates the novel Mpro/TMPRSS2 bispecific inhibitor TMP1 not only suppresses the infection of SARS-CoV-2 but also potently protects against other seasonal and highly-pathogenic coronaviruses. This evidence concerns the gene TMPRSS2 and infection.